Gastroenterology News

SARS-CoV-2 infection, especially a severe case or without vaccination, significantly increases the long-term risk for developing autoimmune and autoinflammatory connective tissue diseases, according to data published in JAMA Dermatology.

A 2020 McKinsey survey showed 84% of respondents have experienced workplace microaggressions, with additional challenges reported among women, individuals from historically underrepresented groups and members of the LGBTQ+ community.

Considering “paradigm-shifting changes” in the diagnosis and management of eosinophilic esophagitis, the ACG released an updated guideline on treatment, monitoring and maintenance as well as pediatric-specific recommendations.

Throughout 2024, experts in the fields of gastroenterology and hepatology weighed in on cutting edge research, emerging trends and policies, as well as clinical innovations shaping the future of patient care.

Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially the first FDA-approved blood test. However, experts are unsure whether these will be as effective as colonoscopy.

The expansion of safe and effective FDA-approved biosimilars for inflammatory bowel disease set to launch in early 2025 may improve access to care, with the potential to reduce health care costs and revolutionize the treatment landscape.

Although constipation affects millions of people worldwide, it remains one of the least discussed health concerns due to social stigma, according to a press release from the International Foundation for Gastrointestinal Disorders.

In this podcast episode, Larry Kosinski, MD, founder of SonarMD, discusses reclaiming GI services for patients and physicians, developing new tools for IBD patients and more.

A centralized colorectal cancer screening intervention boosted fecal immunochemical test completion, as well as follow-up colonoscopy, among average-risk individuals served by federally qualified health centers, according to research.